IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $923,000 | -3.9% | 18,200 | -3.6% | 0.01% | 0.0% |
| Q2 2017 | $960,000 | +30.4% | 18,876 | +3.1% | 0.01% | +20.0% |
| Q1 2017 | $736,000 | -13.0% | 18,303 | +3.4% | 0.01% | -16.7% |
| Q4 2016 | $846,000 | +21.4% | 17,695 | -6.9% | 0.01% | 0.0% |
| Q3 2016 | $697,000 | +82.5% | 19,011 | +15.8% | 0.01% | +100.0% |
| Q2 2016 | $382,000 | -71.0% | 16,417 | -49.6% | 0.00% | -75.0% |
| Q1 2016 | $1,318,000 | -31.1% | 32,546 | +5.4% | 0.01% | -33.3% |
| Q4 2015 | $1,912,000 | – | 30,867 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |